10.1016/j.amjcard.2018.11.02730527777 151 Yang B, Ma K, Xiang R, et al
The inhibition of glutamine metabolism has emerged as a promising avenue for cancer therapy, with CB-839, IPN60090, and DRP-104 representing exciting new drugs that hold significant potential
Study approval All animal work was performed following the guidelines of and with the approval of the University of Pennsylvanias IACUC (approval protocol number 804892)
Glutathione is generally well-tolerated but may interact with certain medications or worsen symptoms in G6PD deficiency and some autoimmune conditions
Illegal use of Melanotan I and II has been reported and regulatory authorities have issued warnings in the United States and Europe.1,2 Melatonin I and II are synthetic melanocortin analogs ( melanocyte-stimulating hormone) with greater potency and a longer half-life than endogenous melanocyte-stimulating hormone
Precise evaluation and management are vital for older adults with low vitamin B12 levels
